|
Oncogenes and Tumor Suppressors
Citations 401-410 of 795 total displayed.
|
Past content
(since May 2000):
|
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF- B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells
- Liza Ho, R. Eric Davis, Béatrice Conne, Richard Chappuis, Margaret Berczy, Paulette Mhawech, Louis M. Staudt, and Juerg Schwaller
Blood 2005; 105: 2891-2899.
[Abstract]
[Full text]
[PDF]
Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11
- Sean F. Landrette, Ya-Huei Kuo, Karen Hensen, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Paola N. Perrat, Wim J. M. Van de Ven, Ruud Delwel, and Lucio H. Castilla
Blood 2005; 105: 2900-2907.
[Abstract]
[Full text]
[PDF]
RNAi-induced down-regulation of FLT3 expression in AML cell lines increases sensitivity to MLN518
- Denise K. Walters, Eric P. Stoffregen, Michael C. Heinrich, Michael W. Deininger, and Brian J. Druker
Blood 2005; 105: 2952-2954.
[Abstract]
[Full text]
[PDF]
Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia
- Alfonso Quintas-Cardama, Hagop Kantarjian, Moshe Talpaz, Susan O'Brien, Guillermo Garcia-Manero, Srdan Verstovsek, Mary Beth Rios, Kimberly Hayes, Armand Glassman, B. Nebiyou Bekele, Xian Zhou, and Jorge Cortes
Blood 2005; 105: 2281-2286.
[Abstract]
[Full text]
[PDF]
A novel NF-B inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors
- Akane Tanaka, Masayo Konno, Susumu Muto, Naotomo Kambe, Eiichi Morii, Tatsutoshi Nakahata, Akiko Itai, and Hiroshi Matsuda
Blood 2005; 105: 2324-2331.
[Abstract]
[Full text]
[PDF]
Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line
- Ingo Melzner, Alexandra Juliana Bucur, Silke Brüderlein, Karola Dorsch, Cornelia Hasel, Thomas F. E. Barth, Frank Leithäuser, and Peter Möller
Blood 2005; 105: 2535-2542.
[Abstract]
[Full text]
[PDF]
Punish the parent not the progeny
- Lucy J. Elrick, Heather G. Jorgensen, Joanne C. Mountford, and Tessa L. Holyoake
Blood 2005; 105: 1862-1866.
[Abstract]
[Full text]
[PDF]
PKC plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant
- Tanya Jelacic and Diana Linnekin
Blood 2005; 105: 1923-1929.
[Abstract]
[Full text]
[PDF]
Induction of BCR-ABL–specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells
- Yi Zeng, Michael W. Graner, Sylvia Thompson, Marilyn Marron, and Emmanuel Katsanis
Blood 2005; 105: 2016-2022.
[Abstract]
[Full text]
[PDF]
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment
- Su Chu, Helen Xu, Neil P. Shah, David S. Snyder, Stephen J. Forman, Charles L. Sawyers, and Ravi Bhatia
Blood 2005; 105: 2093-2098.
[Abstract]
[Full text]
[PDF]
|
|
